TORONTO, ONTARIO--(Marketwire - May 14, 2010) - ISee3D Inc. (TSX VENTURE:ICT) announced today it has retained Scarsdale Equities LLC's healthcare banking team in New York to act as ISee3D's agent to generate non-equity licensing of ISee3D's technology in advanced healthcare and medical applications worldwide.
Scarsdale Equities' healthcare banking specialists, staffed by healthcare professionals, will commence licensing efforts in healthcare and medical fields including, but not limited to, diagnostics, minimally invasive surgery, oncology, ophthalmology and dentistry. The licensing efforts will cover the application of ISee3D technologies in microscopes, colonoscopes, bronchoscopes, endoscopes, arthroscopes, and borescopes.
ISee3D CEO Dwight Romanica said "We believe our technology has the potential for broad acceptance within endoscopy and microscopy. For example, having previously developed and received FDA approval for an endoconverter system to create realistic 3D images for a surgeon to perform minimally invasive surgery, the company is focused on re-introducing the next generation HD version of the technology to endoscope manufacturers worldwide.
ISee3D has adapted its single lens, single camera technology to allow microscopes to work at up to 1,200 times magnification. This microscope initiative is market driven and serves a wide market base in the research sector, where 3D visualization provides a marked improvement over existing systems today.
We believe that the Scarsdale Equities healthcare banking team will greatly assist ISee3D in maximizing market penetration and licensing revenue in worldwide healthcare applications. Key factors in our selection included Scarsdale Equities' market intelligence, access to key potential licenses and understanding of the broad licensing opportunities.
We expect Scarsdale Equities to support the worldwide healthcare applications licensing process generating situations to out-license the technology in a timely manner," concluded Romanica.
About Scarsdale Equities
Scarsdale Equities LLC is an institutional broker-dealer located in New York City. The founding partners of Scarsdale Equities LLC are veterans of the U.S. financial services industry as investment bankers, investors and analysts. The firm's services include investment banking, institutional equity brokerage, discretionary account management, and start-up consulting and advisory services for money managers. Special focus is devoted to healthcare investment opportunities, and Scarsdale has built a healthcare group staffed by healthcare centric professionals with extensive formal education and experience in medical devices, diagnostics and therapeutics. The firm is a member of the Financial Industry Regulatory Authority (FINRA) and Securities Investor Protection Corp. (SIPC). The firm's website is located at www.scarsdale-equities.com.